Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function
暂无分享,去创建一个
B. Fredholm | B. Cronstein | E. Stanley | V. Chitu | Firas M. Kara | J. Sloane | M. Axelrod | Jennifer E. Sloane
[1] E. Lewiecki,et al. Osteoporosis , 2011, Annals of Internal Medicine.
[2] B. Fredholm,et al. Adenosine A(1) receptors regulate bone resorption in mice: adenosine A(1) receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A(1) receptor-knockout mice. , 2010, Arthritis and rheumatism.
[3] R. Berne,et al. Effects of hypoxia and ischaemia on coronary vascular resistance, A-V node conduction and S-A node excitation. , 2009, Acta medica Scandinavica. Supplementum.
[4] L. Chiriboga,et al. Amendment history : Corrigendum ( April 2009 ) Adenosine signaling contributes to ethanol-induced fatty liver in mice , 2018 .
[5] U. Lerner,et al. Calcitonin inhibits osteoclast formation in mouse haematopoetic cells independently of transcriptional regulation by receptor activator of NF-{kappa}B and c-Fms. , 2007, The Journal of endocrinology.
[6] Linda Yip,et al. ATP Release Guides Neutrophil Chemotaxis via P2Y2 and A3 Receptors , 2006, Science.
[7] M. Postow,et al. Tumor Necrosis Factor-α Prevents Desensitization of Gαs-Coupled Receptors by Regulating GRK2 Association with the Plasma Membrane , 2006, Molecular Pharmacology.
[8] R. Neubig,et al. Endogenous RGS Proteins and G&agr; Subtypes Differentially Control Muscarinic and Adenosine-Mediated Chronotropic Effects , 2006, Circulation research.
[9] C. Elford,et al. Human Osteoblast Precursors Produce Extracellular Adenosine, Which Modulates Their Secretion of IL‐6 and Osteoprotegerin , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[10] D. Larson,et al. The PCH family member MAYP/PSTPIP2 directly regulates F-actin bundling and enhances filopodia formation and motility in macrophages. , 2005, Molecular biology of the cell.
[11] W. Swat,et al. Vav3 regulates osteoclast function and bone mass , 2005, Nature Medicine.
[12] Y. Wong,et al. G16-mediated Activation of Nuclear Factor κB by the Adenosine A1 Receptor Involves c-Src, Protein Kinase C, and ERK Signaling* , 2004, Journal of Biological Chemistry.
[13] F. Saltel,et al. Apatite-mediated actin dynamics in resorbing osteoclasts. , 2004, Molecular biology of the cell.
[14] Darrell R. Abernethy,et al. International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.
[15] B. Cronstein,et al. Th1 Cytokines Regulate Adenosine Receptors and Their Downstream Signaling Elements in Human Microvascular Endothelial Cells 1 , 2003, The Journal of Immunology.
[16] L. Pott,et al. G Protein‐Independent Inhibition of GIRK Current by Adenosine in Rat Atrial Myocytes Overexpressing A1 Receptors after Adenovirus‐Mediated Gene Transfer , 2003, The Journal of physiology.
[17] S. M. Sims,et al. Regulation of Osteoclasts by Calcitonin and Amphiphilic Calcitonin Conjugates: Role of Cytosolic Calcium , 2003, Calcified Tissue International.
[18] Hong-Hee Kim,et al. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. , 2003, Biochemical and biophysical research communications.
[19] E. Wagner,et al. Reaching a genetic and molecular understanding of skeletal development. , 2002, Developmental cell.
[20] R. Ye. Regulation of nuclear factor κB activation by G‐protein‐coupled receptors , 2001, Journal of leukocyte biology.
[21] B. Fredholm,et al. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. , 2001, Pharmacological reviews.
[22] B. Cronstein,et al. Inflammatory Cytokines Regulate Function and Expression of Adenosine A2A Receptors in Human Monocytic THP-1 Cells1 , 2001, The Journal of Immunology.
[23] B. Fredholm,et al. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[24] Dianqing Wu,et al. Gα16 Couples Chemoattractant Receptors to NF-κB Activation1 , 2001, The Journal of Immunology.
[25] S. Dixon,et al. Osteoclast ion channels: potential targets for antiresorptive drugs. , 2001, Current pharmaceutical design.
[26] M. Si-Tahar,et al. Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6. , 2001, The Journal of clinical investigation.
[27] M. Nomura,et al. Effect of γ‐butyrobetaine on fatty liver in juvenile visceral steatosis mice , 2001 .
[28] S. Teitelbaum,et al. Bone resorption by osteoclasts. , 2000, Science.
[29] T. Martin,et al. Therapeutic approaches to bone diseases. , 2000, Science.
[30] Wyeth Wasserman,et al. Structure and function of adenosine receptors and their genes , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.
[31] S. M. Sims,et al. Electrophysiological characterization of ion channels in osteoclasts isolated from human deciduous teeth. , 2000, Bone.
[32] S. Manolagas,et al. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. , 2000, Endocrine reviews.
[33] S. Morham,et al. Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture. , 2000, The Journal of clinical investigation.
[34] C. Gatlin,et al. TGF-beta enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF. , 1999, Biochemical and biophysical research communications.
[35] C. Gay,et al. Depolarization of Osteoclast Plasma Membrane Potential by 17β‐Estradiol , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[36] N. Udagawa,et al. A novel molecular mechanism modulating osteoclast differentiation and function. , 1999, Bone.
[37] Sakae Tanaka,et al. Severe osteopetrosis, defective interleukin‐1 signalling and lymph node organogenesis in TRAF6‐deficient mice , 1999, Genes to cells : devoted to molecular & cellular mechanisms.
[38] T. Martin,et al. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. , 1999, Endocrine reviews.
[39] S. Morony,et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. , 1999, Genes & development.
[40] T. Chambers,et al. Prostaglandin E2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: synergistic activation of differentiation, cell spreading, and fusion. , 1999, Endocrinology.
[41] R. Steinman,et al. The TRAF Family of Signal Transducers Mediates NF-κB Activation by the TRANCE Receptor* , 1998, The Journal of Biological Chemistry.
[42] C. Taylor,et al. Neutrophil-derived 5′-Adenosine Monophosphate Promotes Endothelial Barrier Function via CD73-mediated Conversion to Adenosine and Endothelial A2B Receptor Activation , 1998, The Journal of experimental medicine.
[43] G. Daculsi,et al. Cytokines, growth factors and osteoclasts. , 1998, Cytokine.
[44] B. Cronstein,et al. Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides. , 1998, The Journal of clinical investigation.
[45] Ulrich Siebenlist,et al. Requirement for NF-κB in osteoclast and B-cell development , 1997 .
[46] G. Burnstock,et al. Purinergic transmitters inhibit bone formation by cultured osteoblasts. , 1997, Bone.
[47] S. M. Sims,et al. Extracellular Nucleotides Activate non‐Selective Cation and Ca2+‐Dependent K+ Channels in Rat Osteoclasts , 1997, The Journal of physiology.
[48] J. Blay,et al. The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. , 1997, Cancer research.
[49] L. Aiello,et al. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. , 1996, Investigative ophthalmology & visual science.
[50] R. Baron. Molecular mechanisms of bone resorption. An update. , 1995, Acta orthopaedica Scandinavica. Supplementum.
[51] M Horton,et al. The osteoclast clear zone is a specialized cell-extracellular matrix adhesion structure. , 1995, Journal of cell science.
[52] I. Owan,et al. Postmitotic osteoclast precursors are mononuclear cells which express macrophage-associated phenotypes. , 1994, Developmental biology.
[53] N. Standen,et al. Adenosine‐activated potassium current in smooth muscle cells isolated from the pig coronary artery. , 1993, The Journal of physiology.
[54] M. Noble,et al. Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbtsA58 transgenic mouse. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[55] R. Mrsny,et al. 5'-adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers. , 1993, The Journal of clinical investigation.
[56] M. Zaidi,et al. Regulation of cytosolic free calcium in isolated rat osteoclasts by calcitonin. , 1992, The Journal of endocrinology.
[57] K. Väänänen,et al. Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[58] M. Simon,et al. G alpha 16, a G protein alpha subunit specifically expressed in hematopoietic cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[59] J. Schrader,et al. Adenine nucleotide release from isolated perfused guinea pig hearts and extracellular formation of adenosine. , 1991, Circulation research.
[60] T. Dunwiddie,et al. Adenosine A1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus. , 1989, The Journal of pharmacology and experimental therapeutics.
[61] H. Granger,et al. Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. , 1988, The American journal of physiology.
[62] Martin J. Lohse,et al. 8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) — a selective high affinity antagonist radioligand for A1 adenosine receptors , 1987, Naunyn-Schmiedeberg's Archives of Pharmacology.
[63] J. Schrader,et al. Contribution of coronary endothelial cells to cardiac adenosine production , 1986, Pflügers Archiv.
[64] J. Pearson,et al. Vascular endothelial and smooth muscle cells in culture selectively release adenine nucleotides , 1979, Nature.
[65] A. Malik,et al. G alpha 16 couples chemoattractant receptors to NF-kappa B activation. , 2001, Journal of immunology.
[66] T. Taniguchi,et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. , 2000, Nature.
[67] W. Ho,et al. Modulation of ATP-sensitive K+ channels in rabbit ventricular myocytes by adenosine A1 receptor activation. , 1997, The American journal of physiology.
[68] A. Leonardi,et al. Requirement for NF-kappaB in osteoclast and B-cell development. , 1997, Genes & development.
[69] B. Cronstein,et al. Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis. , 1997, Arthritis and rheumatism.
[70] A. Tucker,et al. Cloned receptors and cardiovascular responses to adenosine. , 1993, Cardiovascular research.